Follow
Share
"Testing is still ongoing at this time..."

Do you mean the drug is in clinical-trial stage? Or your Mom is being tested?
Helpful Answer (0)
Reply to Geaton777
Report

Sorry, this is not a question for my mom. I forgot to mention that this is for new family member that is just being diagnosed at the age of 71 with potential early dementia. Testing is still ongoing at this time
Helpful Answer (0)
Reply to MiddleSisterPIA
Report

Is a doctor offering this to your mother at this stage ?
Or is this speculation amongst the family?
Either way don’t poke mom with needles . Infusion is not going to do anything substantial to improve her life at this stage , if at all.
Why slow down the progression and cause a longer miserable decline ?

Your family needs to read about the later stages of this awful disease . They don’t get it .

An antidepressant for Mom could be tried.
Helpful Answer (3)
Reply to waytomisery
Report

I agree with Lea. You even say Mom is past having caregiversbin her home. She is also past slowing down of any type of Dementia. This is just what it is.

Tell sister this...the Law considers your Mom a resident, not a patient, and says she cannot be forced to do anything she does not want to do Alz or not.
Helpful Answer (0)
Reply to JoAnn29
Report

Surely you are not thinking of infusions for a 98 yr old mother with Alzheimer's???? Why would you want to put a 98 year old through such a thing, and extend her suffering??? Please. Think long and hard about such a thing. Especially if the treatment is a "mab".....medication ending with those letters, meaning it's a monoclonal antibody. A form of immunotherapy which has horrible side effects. There is one new drug out for AD which is a mab and includes brain bleeds as a possible side effect, and brain swelling! I'll have to look up the name....

Here it is.....The newest approved biologics for Alzheimer's are anti-amyloid monoclonal antibodies like Lecanemab (Leqembi) and Donanemab (Kisunla), which target and clear beta-amyloid plaques in the brain, slowing disease progression in early stages, unlike older drugs that only manage symptoms. Both are given as IV infusions and carry risks like brain swelling/bleeding (ARIA), requiring MRI monitoring, with Leqembi also recently getting approval for subcutaneous injection. 😐

These drugs are used for EARLY Alzheimer's.
Helpful Answer (5)
Reply to lealonnie1
Report

Ask a Question
Subscribe to
Our Newsletter